N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide

C142H183N19O10 — CID 158841737

IUPACN-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide
SMILESC=CCN1C2CCC1CN(C(c1ccc(C(=O)NC3CCCCCC3)cc1)c1cccc(O)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCC3)cc1)c1cccc(O)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCC3)cc1)c1cccc(OC)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCCC3)cc1)c1cccc(O)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCCC3)cc1)c1cccc(OC)c1)C2
InChIInChI=1S/C30H39N3O2.C29H38N4O2.2C28H36N4O2.C27H34N4O2/c1-2-18-33-26-16-17-27(33)21-32(20-26)29(24-8-7-11-28(34)19-24)22-12-14-23(15-13-22)30(35)31-25-9-5-3-4-6-10-25;1-3-16-33-25-14-15-26(33)21-31(20-25)28(24-8-7-9-27(19-24)35-2)22-10-12-23(13-11-22)29(34)30-32-17-5-4-6-18-32;1-3-15-32-24-13-14-25(32)20-30(19-24)27(23-7-6-8-26(18-23)34-2)21-9-11-22(12-10-21)28(33)29-31-16-4-5-17-31;1-2-15-32-24-13-14-25(32)20-30(19-24)27(23-7-6-8-26(33)18-23)21-9-11-22(12-10-21)28(34)29-31-16-4-3-5-17-31;1-2-14-31-23-12-13-24(31)19-29(18-23)26(22-6-5-7-25(32)17-22)20-8-10-21(11-9-20)27(33)28-30-15-3-4-16-30/h2,7-8,11-15,19,25-27,29,34H,1,3-6,9-10,16-18,20-21H2,(H,31,35);3,7-13,19,25-26,28H,1,4-6,14-18,20-21H2,2H3,(H,30,34);3,6-12,18,24-25,27H,1,4-5,13-17,19-20H2,2H3,(H,29,33);2,6-12,18,24-25,27,33H,1,3-5,13-17,19-20H2,(H,29,34);2,5-11,17,23-24,26,32H,1,3-4,12-16,18-19H2,(H,28,33)
InChIKeyIYIGKFDKASZVKF-UHFFFAOYSA-N
MW2316.15 g/mol
LogP20.88
Rot. Bonds37

About N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide

N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide (PubChem CID 158841737) has the molecular formula C142H183N19O10 and a molecular weight of 2316.15 g/mol. Its IUPAC name is N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide.

Molecular Properties

Compound NameN-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide
PubChem CID158841737
Molecular FormulaC142H183N19O10
Molecular Weight2316.15 g/mol
Exact Mass2314.44
IUPAC NameN-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide
SMILESC=CCN1C2CCC1CN(C(c1ccc(C(=O)NC3CCCCCC3)cc1)c1cccc(O)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCC3)cc1)c1cccc(O)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCC3)cc1)c1cccc(OC)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCCC3)cc1)c1cccc(O)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCCC3)cc1)c1cccc(OC)c1)C2
InChIInChI=1S/C30H39N3O2.C29H38N4O2.2C28H36N4O2.C27H34N4O2/c1-2-18-33-26-16-17-27(33)21-32(20-26)29(24-8-7-11-28(34)19-24)22-12-14-23(15-13-22)30(35)31-25-9-5-3-4-6-10-25;1-3-16-33-25-14-15-26(33)21-31(20-25)28(24-8-7-9-27(19-24)35-2)22-10-12-23(13-11-22)29(34)30-32-17-5-4-6-18-32;1-3-15-32-24-13-14-25(32)20-30(19-24)27(23-7-6-8-26(18-23)34-2)21-9-11-22(12-10-21)28(33)29-31-16-4-5-17-31;1-2-15-32-24-13-14-25(32)20-30(19-24)27(23-7-6-8-26(33)18-23)21-9-11-22(12-10-21)28(34)29-31-16-4-3-5-17-31;1-2-14-31-23-12-13-24(31)19-29(18-23)26(22-6-5-7-25(32)17-22)20-8-10-21(11-9-20)27(33)28-30-15-3-4-16-30/h2,7-8,11-15,19,25-27,29,34H,1,3-6,9-10,16-18,20-21H2,(H,31,35);3,7-13,19,25-26,28H,1,4-6,14-18,20-21H2,2H3,(H,30,34);3,6-12,18,24-25,27H,1,4-5,13-17,19-20H2,2H3,(H,29,33);2,6-12,18,24-25,27,33H,1,3-5,13-17,19-20H2,(H,29,34);2,5-11,17,23-24,26,32H,1,3-4,12-16,18-19H2,(H,28,33)
InChIKeyIYIGKFDKASZVKF-UHFFFAOYSA-N
XLogP20.88
TPSA270.01 Ų
H-Bond Donors8
H-Bond Acceptors24
Rotatable Bonds37
Heavy Atoms171
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002316.15
LogP ≤ 520.88
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide?
The IUPAC name of N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide (CID 158841737) is N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide.
What is the SMILES notation for N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide?
The canonical SMILES for N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide is C=CCN1C2CCC1CN(C(c1ccc(C(=O)NC3CCCCCC3)cc1)c1cccc(O)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCC3)cc1)c1cccc(O)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCC3)cc1)c1cccc(OC)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCCC3)cc1)c1cccc(O)c1)C2.C=CCN1C2CCC1CN(C(c1ccc(C(=O)NN3CCCCC3)cc1)c1cccc(OC)c1)C2.
What is the InChIKey of N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide?
The InChIKey is IYIGKFDKASZVKF-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H39N3O2.C29H38N4O2.2C28H36N4O2.C27H34N4O2/c1-2-18-33-26-16-17-27(33)21-32(20-26)29(24-8-7-11-28(34)19-24)22-12-14-23(15-13-22)30(35)31-25-9-5-3-4-6-10-25;1-3-16-33-25-14-15-26(33)21-31(20-25)28(24-8-7-9-27(19-24)35-2)22-10-12-23(13-11-22)29(34)30-32-17-5-4-6-18-32;1-3-15-32-24-13-14-25(32)20-30(19-24)27(23-7-6-8-26(18-23)34-2)21-9-11-22(12-10-21)28(33)29-31-16-4-5-17-31;1-2-15-32-24-13-14-25(32)20-30(19-24)27(23-7-6-8-26(33)18-23)21-9-11-22(12-10-21)28(34)29-31-16-4-3-5-17-31;1-2-14-31-23-12-13-24(31)19-29(18-23)26(22-6-5-7-25(32)17-22)20-8-10-21(11-9-20)27(33)28-30-15-3-4-16-30/h2,7-8,11-15,19,25-27,29,34H,1,3-6,9-10,16-18,20-21H2,(H,31,35);3,7-13,19,25-26,28H,1,4-6,14-18,20-21H2,2H3,(H,30,34);3,6-12,18,24-25,27H,1,4-5,13-17,19-20H2,2H3,(H,29,33);2,6-12,18,24-25,27,33H,1,3-5,13-17,19-20H2,(H,29,34);2,5-11,17,23-24,26,32H,1,3-4,12-16,18-19H2,(H,28,33).
What are the key properties of N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide?
N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide has a molecular weight of 2316.15 g/mol, XLogP of 20.88, 37 rotatable bonds, 8 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for N-cycloheptyl-4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]benzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-hydroxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-piperidin-1-ylbenzamide;4-[(3-methoxyphenyl)-(8-prop-2-enyl-3,8-diazabicyclo[3.2.1]octan-3-yl)methyl]-N-pyrrolidin-1-ylbenzamide is sourced from PubChem (CID 158841737), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).